Cellular Biomedi Shares Up 17.7% Since SmarTrend's Buy Recommendation (CBMG)

SmarTrend identified an Uptrend for Cellular Biomedi (NASDAQ:CBMG) on November 7th, 2018 at $15.96. In approximately 1 month, Cellular Biomedi has returned 17.71% as of today's recent price of...